Pfizer has revealed it was rebuffed once again by AstraZeneca over the weekend about a potential takeover of the UK company, with the latter's shares soaring in early trading today in reaction.
Following a January approach revealed over Easter Bank Holiday, the US pharmaceuticals giant confirmed it had re-contacted AstraZeneca this weekend, only to have its approach rejected once again. It said: "In light of recent market developments, Pfizer contacted AstraZeneca on 26 April 2014 seeking to renew discussions in order to develop a proposal that could be recommended by both companies to their shareholders. AstraZeneca again declined to engage. Pfizer is currently considering its options with respect to AstraZeneca." The UK firm's shares jumped dramatically this morning to £46...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
